FIBROGEN INC — Director's Dealing 2015

Dec 12, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2015-12-10

Reporting Person: Yu K Peony (VP, Clinical Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-10	Common Stock	S	1093	$28.96	Disposed	176595	Direct

Footnotes

F1: Shares sold pursuant to a 10b5-1 plan.